UPC Analytics
ENDE
Overview · Filed:

ORD_22246/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsCase Management OrdersMunich LDGeneric Order
  • 2025-07-17Procedural onlyproceduralGeneric Order

    The Local Division Munich issued a case management order following an interim conference in parallel infringement proceedings by Sanofi against multiple generics manufacturers (Accord, STADA, Reddy, Zentiva) concerning EP 2 493 466, noting EPO BoA uphold of the patent, scheduling the oral hearing for October 2025, and addressing expert evidence and confidentiality of interim damages calculations.